Literature DB >> 27237784

Warfarin-associated Intraspinal Hematoma.

Joji Inamasu1, Keisuke Ito, Natsuki Hattori, Yuichi Hirose.   

Abstract

Intracerebral hemorrhage is a well-known complication resulting from warfarin use; however, warfarin-associated intraspinal hematoma is very rare. Warfarin-associated intraspinal hematoma may exhibit delayed progression, and patients may present with atypical symptoms, occasionally resulting in delayed diagnosis. We report the case of a 65-year-old man who visited our emergency department (ED) with acute urinary retention. He had been previously diagnosed with non-valvular atrial fibrillation, arterial hypertension, and benign prostatic hyperplasia, and he used warfarin for the prevention of systemic embolism. The patient was initially diagnosed with worsening of the prostatic hyperplasia. After 2 days, he revisited the ED with painless paraparesis. Magnetic resonance imaging of the thoracic spine revealed an intraspinal hematoma at Th7-8, and blood coagulation tests indicated a prothrombin time-international normalized ratio of 3.33. Despite attempts to reverse the effects of warfarin with vitamin K administration, the paraparesis progressed to paraplegia, necessitating urgent surgical removal of the hematoma. Partial recovery of motor function was evident after surgery. From the present case, we learned that intraspinal hematoma should be included in the differential diagnosis of patients using warfarin who present with acute urinary retention. Although there are no evidence-based treatment guidelines for warfarin-associated intraspinal hematoma, surgical treatment may be warranted for those who exhibit neurological deterioration.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27237784     DOI: 10.2302/kjm.2015-0012-CR

Source DB:  PubMed          Journal:  Keio J Med        ISSN: 0022-9717


  1 in total

1.  Presumptive Haematomyelia Secondary to Warfarin Toxicosis in a Dog.

Authors:  Carlos Blanco; Meritxell Moral; Juan José Minguez; Valentina Lorenzo
Journal:  Case Rep Vet Med       Date:  2022-08-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.